Spence McClelland

Spence McClelland joined NMP in 2010 and supports the firm’s investments in healthcare, software and tech-enabled services. Spence is focused on reviewing investment opportunities and working with portfolio company management teams to develop and execute their strategic plans. He currently serves on the boards of Enable Dental, Envera Health, findhelp, Medix Infusion, and Pure Life Renal and as a board observer for Trilliant Health. Spence previously was on the boards of Change Healthcare (acquired by Emdeon), Contessa Health (acquired by Amedisys), Hospicelink (acquired by StateServ Medical/Blue Wolf Capital), Icario (acquired by CVC Capital Partners), and Trilliant Health (acquired by Primus Capital) and he worked on the firm’s successful investments in Acumen Brands and Wellcentive.

Prior to joining NMP, Spence worked in the corporate development group of Healthways, Inc., where he was responsible for identifying, evaluating and executing acquisitions and strategic partnerships for the company. In addition, he developed numerous business plans on potential new markets, channels and business models for the company’s solutions. Spence was also an associate with the private equity firm Willis Stein & Partners and worked in the investment banking groups of J.C. Bradford and DLJ. Spence is a past chairman of Venture Atlanta. He received a BA from Vanderbilt University, where he was a member of Phi Beta Kappa, and an MBA with distinction from the Kellogg School of Management at Northwestern University.